Volume 10, Issue 3 (2024)
Pharm Biomed Res 2024, 10(3): 167-178 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kumar G N, D R B, K C, B M J, Ahmed S S. Revolutionizing Care: A Comprehensive Review of Modern Diabetes Research Advancements. Pharm Biomed Res 2024; 10 (3) :167-178
URL: http://pbr.mazums.ac.ir/article-1-583-en.html
URL: http://pbr.mazums.ac.ir/article-1-583-en.html
1- Department of Pharmacology, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, Nagamangala, India.
2- Sri Adichunchanagiri college of pharmacy, Adichunchanagiri University
2- Sri Adichunchanagiri college of pharmacy, Adichunchanagiri University
Abstract: (1130 Views)
Background: Diabetes mellitus, a multifaceted metabolic disorder with diverse etiologies, has remained a significant global health concern, imposing a substantial burden on healthcare systems.
Objectives: This review aims to explore contemporary advancements in diabetes research, shedding light on recent breakthroughs and their potential impact.
Methods: A thorough examination of current literature was conducted to identify critical areas in diabetes research. Precision medicine, innovative therapies, biomarker discovery, and technology integration, including artificial intelligence (AI), in diabetes care were investigated to provide a comprehensive overview.
Results: The review highlights the emergence of precision medicine as a promising avenue in diabetes research, emphasizing tailored therapeutic approaches based on individual patient characteristics. Innovative therapies, such as gene therapies and advanced pharmacological interventions, present novel strategies for effective diabetes management. Biomarker discovery is a key focus, which helps identify reliable indicators for early diagnosis and personalized treatment strategies. Incorporating technology, including continuous glucose monitoring and insulin delivery systems, reflects a paradigm shift in diabetes care.
Conclusion: This review underscores the dynamic landscape of diabetes research, emphasizing the crucial role of precision medicine, innovative therapies, biomarker discovery, and technology integration in shaping future directions. The evolving role of AI in diabetes care signifies a transformative potential for personalized, data-driven interventions. By providing insights into contemporary advancements, this review contributes to the ongoing efforts to develop more effective prevention and management strategies for diabetes, addressing the pressing global health challenge posed by this complex metabolic disorder.
Objectives: This review aims to explore contemporary advancements in diabetes research, shedding light on recent breakthroughs and their potential impact.
Methods: A thorough examination of current literature was conducted to identify critical areas in diabetes research. Precision medicine, innovative therapies, biomarker discovery, and technology integration, including artificial intelligence (AI), in diabetes care were investigated to provide a comprehensive overview.
Results: The review highlights the emergence of precision medicine as a promising avenue in diabetes research, emphasizing tailored therapeutic approaches based on individual patient characteristics. Innovative therapies, such as gene therapies and advanced pharmacological interventions, present novel strategies for effective diabetes management. Biomarker discovery is a key focus, which helps identify reliable indicators for early diagnosis and personalized treatment strategies. Incorporating technology, including continuous glucose monitoring and insulin delivery systems, reflects a paradigm shift in diabetes care.
Conclusion: This review underscores the dynamic landscape of diabetes research, emphasizing the crucial role of precision medicine, innovative therapies, biomarker discovery, and technology integration in shaping future directions. The evolving role of AI in diabetes care signifies a transformative potential for personalized, data-driven interventions. By providing insights into contemporary advancements, this review contributes to the ongoing efforts to develop more effective prevention and management strategies for diabetes, addressing the pressing global health challenge posed by this complex metabolic disorder.
Keywords: Diabetes mellitus (DM), Biomarkers, Precision medicine, Innovative treatment approaches, Telemedicine
Type of Study: Review article |
Subject:
Pharmacology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
